Recent BioUtah News & Events

SALT LAKE CITY, UTAH—Spectrum Solutions, LLC today announced the U.S. Food and Drug Administration (FDA) has granted 510(k) Class II clearance to the SDNA Saliva Collection Device as a microbial nucleic acid storage and stabilization device. The SDNA device is driving a new era of healthcare that turns to salivary collection and preservation as a […]

Next-generation system helps improve surgical precision to enhance patient care in breast and other soft tissue cancer treatment SOUTH JORDAN, Utah, Feb. 16, 2023 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today the FDA has granted Breakthrough Device Designation for the SCOUT MD […]

HHS released on Tuesday, three new payment models that will be tested through the Centers for Medicare & Medicaid Services Innovation Center (CMS Innovation Center) to see whether they lower high drug costs under Medicare and Medicaid. The models are outlined as part of a larger HHS report conducted in response to an executive order […]

BioUtah continues to monitor issues of importance to our industry and engage with legislators on Utah’s Capitol Hill.

R-Zero’s UV-C Technology Improves Indoor Air Quality for Millions of People; Reduces Reliance on HVAC Systems and Chemicals that Harm Environment

Facility will produce high-performance ceramic armor products for personnel, aircraft, and vehicles

SINTX Technologies Announces Closing of $12.0 Million Public Offering

The Utah State Legislature has hit its halfway point in the 2023 session. Since day one, BioUtah President and CEO, Kelvyn Cullimore, and industry lobbyist, Chris Bleak, have been on the Hill engaging with lawmakers on a number of issues that impact our industry. Yesterday, Cullimore testified before the House Health and Human Services Committee […]

US FDA 510(k) Clearance and CLIA-waiver for the fast and innovative BIOFIRE® SPOTFIRE® System

Renalytix announces a c.$20.3 million private placement

Sumitomo Pharma Oncology presented new data from the ongoing Phase 1/2 study evaluating TP-3654.

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier for the treatment of neurodegenerative diseases and lysosomal storage diseases, today announced that its partner Sanofi has commenced dosing in a Phase 2 study […]

NHP-specific ELISAs now available from Quansys Biosciences

Utah’s vibrant life sciences industry was on full display January 27 as part of the Governor’s Office of Economic Opportunity “Life Sciences Day on the Hill”. The event, held at the state capitol, provided lawmakers the opportunity to interact one-on-one with leaders from local med tech, biotech and diagnostics companies. More than two dozen companies […]

SALT LAKE CITY, Jan. 20, 2023 /PRNewswire/ — Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced completion of a 26,000 sq. ft. expansion of its Monroe, CTfacility.  The Monroe facility is the headquarters of Biomerics’ micro-metals processing business and specializes in the design, development, and manufacture of complex […]

Intermountain Healthcare has now officially changed its name to Intermountain Health, reflecting an added emphasis on keeping people healthy, as well as continuing to provide world-class medical care at its hospitals and clinics. Intermountain Health announced the name change in 2022 and that the name would be officially changed in 2023. The name change was […]

DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease

POSITIVE TWO-YEAR CLINICAL DATA ANNOUNCED FOR STUDY OF DISCOGENIC PROGENITOR CELL THERAPY (IDCT) FOR DEGENERATIVE DISC DISEASE

Award for consortium of industry, academic and clinical research leaders to develop personalized drug response tests in chronic kidney disease

Halia Therapeutics announced the appointment of Dr. Margit M. Janát-Amsbury, MD, Ph.D. as the company’s Chief Medical Officer

ARUP Laboratories and the University of Utah’s Division of Medical Laboratory Sciences have secured $3 million in federal funding.

Inherent Biosciences has teamed up with Posterity Health, the only virtual Male Fertility Center of Excellence, to address male fertility

Significant milestone will make KidneyIntelX accessible to 960,000 veterans with chronic kidney disease

New Catheter-Delivered Embolic Shows Promise for Treating Life-Threatening Bleeding around the Brain